Volume 8, Number 5—May 2002
Correction
Correction, Vol. 8, No. 2
Table 2
Genomovar or species of Burkholderia cepacia complex or phenotypically similar isolates from cystic fibrosis patients in Canada
| Species or genomovar | No. of patients infected with species or genomovara | Percentage of patients (%) |
|---|---|---|
| Genomovar I | 1 | 0.2 |
| Burkholderia multivorans (genomovar II) | 43 | 9.6 |
| Genomovar III | 369 | 82.5 |
| Burkholderia stabilis (genomovar IV) | 17 | 3.8 |
| Burkholderia vietnamiensis (genomovar V) | 7 | 1.6 |
| Burkholderia cepacia complex (not genomovar I-VII) | 8 | 1.8 |
| Burkholderia fungorum | 1 | 0.2 |
| Burkholderia gladioli | 5 | 1.1 |
| Ralstonia pickettii | 5 | 1.1 |
| Pandoraea spp. | 5 | 1.1 |
| Total | 461a |
aSome patients were counted twice if two or more different strains were recovered; therefore, the percentage of patients is based on a denominator of 447.
Page created: June 28, 2012
Page updated: June 28, 2012
Page reviewed: June 28, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.